Micron Waste Secures Key Patents As It Looks to Cannabis and Beyond
January 18, 2019
Ryan Allway January 18th, 2019 Exclusive, News, Top News Organic waste disposal is a problem facing a wide range of industries, including food services and processing, brewing and spirits, pulp and paper, biological pharmaceuticals, and even the nascent cannabis industry. With growing government regulation of pollutants and increased corporate... Read more
Why Investors Should Be Focusing on Cannabis Edibles
January 16, 2019
Ryan Allway January 16th, 2019 Exclusive, News, Top News Cannabis edibles are rapidly taking market share from flower. While there are many startups targeting the edibles space, investors may want to consider companies that have already established a reputable brand and distribution network. These companies may be better positioned... Read more
FSD Pharma Announces Holdings in Cannara Biotech Inc.
January 11, 2019
Canada NewsWire TORONTO, Jan. 11, 2019 TORONTO, Jan. 11, 2019 /CNW/ – FSD Pharma (“FSD“) announced today that, in connection with the business combination (the “Business Combination“) completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the “Issuer“), Cannara Biotech Inc. and 11038427 Canada Inc., FSD... Read more
Gabriella’s Kitchen Adding Seasoned Executives to Its Board
Uncategorized December 20, 2018
Ryan Allway December 20th, 2018 Uncategorized Gabriella’s Kitchen (CSE: GABY) appears to be on the leading edge to service both mainstream grocery and cannabis distribution channels with CBD infused products, as well as CBD and THC-infused edible and wellness products throughout Canada and the U.S. Positioned to be... Read more
Ryan Allway December 20th, 2018 Uncategorized Canada’s cannabis industry may be rapidly growing with new initial public offerings each week, but there has also been a fair share of consolidation within the industry. Investors may want to take a closer look at industry mergers, since they have the... Read more
Canntab & FSD Pharma Make Cannabis More Palatable for Doctors
Uncategorized December 20, 2018
Ryan Allway December 20th, 2018 Uncategorized Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for... Read more
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
December 20, 2018
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
Biome Grow Receives New Consumer Sales Amendment From Health Canada For Its Nova Scotia brand, Highland Grow.
December 17, 2018
Ryan Allway December 17th, 2018 News, Top News Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets Toronto, Ontario (December 17th, 2018) – Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to... Read more
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
December 14, 2018
Ryan Allway December 14th, 2018 Exclusive, Top News The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s... Read more
Biome Grow Signs Massive Provincial Supply Agreement
December 6, 2018
Ryan Allway December 6th, 2018 Exclusive, News, Top Story Canada’s cannabis industry has charged forward full-steam following the legalization of recreational cannabis in October. While there was an initial flurry in provincial agreements, many licensed producers experienced a shortfall in their supply commitments. These dynamics encouraged many provinces... Read more
